| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |